THE DEAL, AT A GLANCE
From the announcementAbridge
01What it doesAbridge operates in Healthcare & Life Sciences and describes its product through its website and announcement materials.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by Spark Capital, GV, VariousFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedAbridge raised $300M Series EFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersAbridge is positioned around AI clinical documentation for health systems where physician documentation burden is framed as a patient safety issue.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Abridge · Financing Record
Explore source-linked visual explanations for Abridge. Unsupported claims are withheld while source review continues.
Record 122 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →